Publication | Closed Access

Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia

Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyImmunologyAutoimmunityPowerful TargetsAdult T-cell Leukemia-lymphomaMedicineCell BiologyMinimal Residual Disease